Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated ...

Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by ...

The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's PODD Omnipod 5 Pods as its most ...

FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...

A breakthrough in insulin delivery could one day spell an end to the invasive needles on which many people with diabetes rely. Using mice, minipigs, and lab-grown human skin samples, scientists have ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 2 diabetes improved time in range after ...

MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated with insulin pump therapy, according to new research to be presented at ...